EMEMORY TECHNOLOGY INC. – Trademark Portfolio
Entity Type: 03
EMEMORY TECHNOLOGY INC. holds 17 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 12 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 8 trademarks are registered. Notable registered marks include NEOEE, ECOBIT, NEOBIT, NEOMTP, and NEOPUF. The owner is based in Hsinchu 30076.
Room 305, No. 47, Park Avenue II Rd.
Science-Based Industrial Park
Hsinchu 30076 R.O.C. , TW
Showing of trademarks Trademarks
Trademark Classifications
EMEMORY TECHNOLOGY INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does EMEMORY TECHNOLOGY INC. have?
EMEMORY TECHNOLOGY INC. has 17 U.S. trademarks filed with the USPTO. Of these, 8 registered, 5 abandoned, 4 cancelled.
What trademark classes does EMEMORY TECHNOLOGY INC. file in?
EMEMORY TECHNOLOGY INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are EMEMORY TECHNOLOGY INC.'s most well-known trademarks?
EMEMORY TECHNOLOGY INC.'s registered trademark portfolio includes well-known marks such as NEOEE, ECOBIT, NEOBIT, NEOMTP, and NEOPUF. These are among 8 currently registered trademarks in the portfolio.
What is EMEMORY TECHNOLOGY INC.'s trademark registration success rate?
EMEMORY TECHNOLOGY INC. has a 47% trademark registration rate, with 8 out of 17 resolved applications resulting in successful registration. Currently, 0 applications are pending review.